Progress in Cardiovascular Diseases
Volume 52, Issue 4 , Pages 336-346, January 2010

Diagnosis and Management of Cardiac Sarcoidosis

  • Simon W. Dubrey

      Affiliations

    • Hillingdon Hospital Uxbridge, United Kingdom
  • ,
  • Rodney H. Falk

      Affiliations

    • Harvard Vanguard Medical Associates, Harvard Medical School, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Rodney H. Falk, MD, Harvard Vanguard Medical Associates, 133, Brookline Ave, Boston, MA 02215.

Abstract 

Cardiac sarcoidosis is an underdiagnosed disease that may be present in as many as 25% of patients with systemic sarcoidosis. Although most commonly recognized in patients with other manifestations of sarcoidosis, it may occur in isolation and its presence is often not appreciated. Cardiac sarcoidosis may present as asymptomatic left ventricular dysfunction, congestive heart failure, atrioventricular block, atrial or ventricular arrhythmia and sudden death. Although untested in clinical trials, early use of high-dose steroid therapy may halt or reverse cardiac damage. This article reviews the clinical manifestations, diagnosis and treatment of sarcoidosis, with an emphasis on new imaging techniques and therapies.

Abbreviations and Acronyms: ACE, angiotensin-converting enzyme, AV, atrioventricular, CT, computed tomography, FDG, fluoro-2-deoxy-d-glucose, MRI, magnetic resonance imaging, PET, positron emission tomography

Keywords: Cardiac MRI, Cardiac PET scan, Cardiac sarcoidosis, Cardiomyopathy, Endomyocardial biopsy, Sarcoidosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Statement of Conflict of Interest: see page 345.

PII: S0033-0620(09)00100-5

doi:10.1016/j.pcad.2009.11.010

Refers to erratum:

  • Erratum to vol 52, no. 4, Jan/Feb 2010

    Progress in Cardiovascular Diseases March 2010 (Vol. 52, Issue 5, Pages 445-447)

Progress in Cardiovascular Diseases
Volume 52, Issue 4 , Pages 336-346, January 2010